Arbutus Biopharma (ABUS)
2.73
-0.02 (0.73%)
Upcoming Events
Latest Headlines
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
April 18, 2024 7:30 AM - Globe NewsWire
Form DEFA14A Arbutus Biopharma Corp
April 10, 2024 4:07 PM - SEC Filing
Form DEF 14A Arbutus Biopharma Corp For: May 22
April 10, 2024 4:06 PM - SEC Filing
Arbutus Biopharma (ABUS) Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna (MRNA)
April 4, 2024 8:35 AM - StreetInsider
Form 8-K Arbutus Biopharma Corp For: Apr 04
April 4, 2024 8:32 AM - SEC Filing
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
April 4, 2024 8:30 AM - Globe NewsWire
Moderna shares fall after judge sides with Arbutus in patent fight
April 3, 2024 2:02 PM - StreetInsider
Arbutus Biopharma (ABUS) Gains, Moderna (MRNA) Declines Following Order in Patent Case
April 3, 2024 1:06 PM - StreetInsider
Arbutus to Participate in Two Upcoming Investor Conferences
March 8, 2024 7:30 AM - StreetInsider
Form 10-K Arbutus Biopharma Corp For: Dec 31
March 5, 2024 4:50 PM - SEC Filing
Form 8-K Arbutus Biopharma Corp For: Feb 29
February 29, 2024 7:32 AM - SEC Filing
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
February 29, 2024 7:30 AM - StreetInsider
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
February 15, 2024 7:30 AM - StreetInsider
Form SC 13G/A Arbutus Biopharma Corp Filed by: Whitefort Capital Management, LP
February 14, 2024 4:39 PM - SEC Filing
Form SC 13G/A Arbutus Biopharma Corp Filed by: Two Seas Capital LP
February 14, 2024 10:48 AM - SEC Filing
Form SC 13G/A Arbutus Biopharma Corp Filed by: BlackRock Inc.
February 12, 2024 9:42 AM - SEC Filing
Form 4 Arbutus Biopharma Corp For: Feb 01 Filed by: Naftzger J. Christopher
February 5, 2024 7:55 PM - SEC Filing
Form 4 Arbutus Biopharma Corp For: Feb 01 Filed by: Sims Karen
February 5, 2024 7:55 PM - SEC Filing
Form 4 Arbutus Biopharma Corp For: Feb 01 Filed by: HASTINGS DAVID C
February 5, 2024 7:55 PM - SEC Filing
Form 4 Arbutus Biopharma Corp For: Feb 01 Filed by: Sofia Michael J.
February 5, 2024 7:54 PM - SEC Filing
Form 4 Arbutus Biopharma Corp For: Feb 01 Filed by: McElhaugh Michael J.
February 5, 2024 7:54 PM - SEC Filing
Full Article List
